What Is Type 1 Diabetes?

Type 1 diabetes is an autoimmune condition in which the body’s immune system mistakenly attacks and destroys the insulin-producing β-cells (beta cells) in the pancreas. As a result, the body produces little to no insulin, and glucose (sugar) cannot properly enter cells, causing elevated blood sugar levels.

Because insulin is essential for moving glucose from the bloodstream into cells (where it is used for energy), people with type 1 diabetes must depend on exogenous (external) insulin to survive.

Type 1 diabetes was once commonly called “juvenile diabetes” or “insulin-dependent diabetes,” though it can develop at any age.

How Common Is It?

• Type 1 diabetes accounts for about 5–10% of all diagnosed diabetes cases.
• In the U.S., approximately 1.7 million adults 20 years or older are living with type 1 diabetes.
• Among children and teens (under 20), there were roughly 304,000 with type 1 diabetes in 2021 in the U.S.
• Globally, incidence rates vary widely by country and region.

Who Gets It / Risk Factors

Type 1 diabetes often develops in children, adolescents, or young adults, but onset at any age is possible.

• Having a family history of type 1 diabetes (such as a parent or sibling) increases risk, but most people with type 1 diabetes do not have a close family member with it.
• Genetic predisposition (certain genes, especially in the HLA region) plays a role.
• An environmental trigger (for instance, viral infections) may initiate or accelerate the autoimmune process in genetically susceptible individuals.

Currently, there is no evidence that diet, lifestyle habits, or obesity directly cause type 1 diabetes. Unlike type 2 diabetes, which is strongly linked to lifestyle and weight, type 1 diabetes develops because of an autoimmune reaction in which the body mistakenly attacks its own insulin-producing cells.

Researchers believe a combination of genetics and environmental factors plays a role, but the exact trigger is still not fully understood. Importantly, type 1 diabetes is not caused by eating too much sugar, being overweight, or making poor lifestyle choices.

Symptoms & Warning Signs

Symptoms of type 1 diabetes can appear suddenly, often over days to weeks. Common signs include:

• Increased thirst (polydipsia)
• Frequent urination (polyuria)
• Extreme hunger (polyphagia)
• Unintentional weight loss
• Fatigue, weakness
• Blurred vision
• Irritability, mood changes
• In children: bedwetting in a child who was previously dry

Because untreated type 1 diabetes can lead to diabetic ketoacidosis (DKA), more severe symptoms may include:

• Nausea, vomiting, abdominal pain
• Deep, rapid breathing
• Dry skin and mouth
• Fruity-smelling breath
• Confusion, lethargy

Diagnosis

Diagnosis is made via blood tests to detect high blood sugar and to distinguish type 1 from type 2 diabetes. Key diagnostic steps include:

• Measuring glucose levels (fasting blood sugar, random glucose, or glucose tolerance tests).
• Testing for autoantibodies (such as GAD, IA-2, insulin autoantibodies) that signal an autoimmune process against beta cells.
• Checking for ketones in urine or blood (especially if DKA is suspected).

Management & Treatment

Insulin Therapy

• Daily injections (multiple daily injections, MDI) or use of an insulin pump (continuous subcutaneous insulin infusion).
• Basal (background) insulin plus bolus (mealtime) insulin to match food intake and maintain glucose stability.

Blood Sugar Monitoring

• Frequent self-monitoring of blood glucose (SMBG), or using continuous glucose monitoring (CGM) devices.
• Adjust insulin doses based on meals, physical activity, and glucose readings.

Lifestyle & Supportive Care

• Healthy eating (balanced diet, carbohydrate counting).
• Regular physical activity.
• Stress management and sleep hygiene.
• Education and ongoing support (self-management skills).
• Regular medical follow-ups and screening for complications.

Emerging & Adjunctive Therapies

Research is underway to improve outcomes, including:

• Immunomodulation / immune therapies aimed at slowing immune attack on β-cells.
• Beta cell preservation / regeneration (stem-cell approaches, islet cell therapies).
• Adjunctive medications (e.g. SGLT inhibitors, GLP-1 receptor agonists) under investigation for use in type 1 diabetes.
• Closed-loop insulin delivery systems (artificial pancreas) combining pump and sensor automation.

Complications & Risks

Poor long-term glucose control can lead to serious complications affecting many organs:

• Cardiovascular disease (heart disease, stroke).
• Kidney disease (nephropathy).
• Nerve damage (neuropathy).
• Eye problems (retinopathy, glaucoma).
• Foot problems and ulcers.
• Increased risk of diabetic ketoacidosis (DKA).
• Hypoglycemia (low blood sugar) is also a frequent risk because of insulin therapy.

People with type 1 may also have other autoimmune conditions (e.g. thyroid disease, celiac disease).

Living with Type 1 Diabetes

With proper care, education, and support, many people with type 1 diabetes can live long, healthy, and active lives. Key strategies include:

• Staying consistent with insulin and dosing adjustments.
• Monitoring and adjusting lifestyle (diet, exercise, stress).
• Learning to spot and treat both high and low blood sugar.
• Regular checkups and screening for complications.
• Emotional and psychosocial support (living with a chronic condition).

Current Research & Future Outlook

Ongoing research aims to shift the landscape of type 1 diabetes care:

• Therapies to slow or prevent autoimmune destruction of beta cells.
• Stem cell and islet transplantation approaches to restore insulin production.
• More advanced closed-loop / hybrid insulin delivery systems for better automatic glucose control.
• Adjunctive therapies (beyond insulin) that might help improve metabolic outcomes.

References